Abstract
The advent of tyrosine kinase inhibitors (TKIs) targeted therapy revolutionized the treatment of chronic myeloid leukemia (CML) patients. However, car......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
